The long-term outcomes of antiretroviral treatment initiated with mono or dual nucleoside reverse transcriptase inhibitors in HIV-1-infected children: an Asian observational study

After a median of 115.9 months of follow-up, 90% of 206 HIV-1-infected children in a cohort in Asia who initiated antiretroviral treatment (ART) with mono or dual nucleoside reverse transcriptase inhibitors were alive and had comparable immunological and virological outcomes as compared to the 1,915...

Descripción completa

Detalles Bibliográficos
Autores principales: Wittawatmongkol, Orasri, Mohamed, Thahira J, Le, Thoa PK, Ung, Vibol, Maleesatharn, Alan, Hansudewechakul, Rawiwan, Nguyen, Lam V, Kumarasamy, Nagalingeswaran, Lumbiganon, Pagakrong, Sudjaritruk, Tavitiya, Bunupuradah, Torsak, Yusoff, Nik KN, Kurniati, Nia, Fong, Moy S., Nallusamy, Revathy, Kariminia, Azar, Sohn, Annette H., Chokephaibulkit, Kulkanya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mediscript Ltd 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827263/
https://www.ncbi.nlm.nih.gov/pubmed/27076917
Descripción
Sumario:After a median of 115.9 months of follow-up, 90% of 206 HIV-1-infected children in a cohort in Asia who initiated antiretroviral treatment (ART) with mono or dual nucleoside reverse transcriptase inhibitors were alive and had comparable immunological and virological outcomes as compared to the 1,915 children who had started with highly active antiretroviral regimens. However, these children had higher rates of treatment-related adverse events, opportunistic infections, and cumulative mortality, and were more likely to require protease inhibitor-containing regimens or other more novel ART-based regimens.

Ejemplares similares